Tracker
CDSCO
342 notices, January 1, 2024 to November 11, 2026
Updated
How the drug, device and cosmetic rules work, from licences to trials: our CDSCO guide.
Open for comment
- 28.10.2026 G.S.R. 956(E) Draft Notification for amendment in the Drugs Rules, 1945 for suspension of product permission for NSQ drug till CAPA is implemented, PDF, opens in a new tab
Comments close about November 28, 2026 to December 4, 2026
30 days from the Gazette of October 29, 2026, put online November 4, 2026
G.S.R. 956(E) ·
- 28.10.2026 G.S.R. 953(E) Draft Notification for amendment in Drugs Rules, 1945 for Revision of Microbial Contamination Limits for Grade A Areas under Schedule M to align with WHO Standards, PDF, opens in a new tab
Comments close about November 28, 2026 to December 3, 2026
30 days from the Gazette of October 29, 2026, put online November 3, 2026
G.S.R. 953(E) ·
- 28.10.2026 G.S.R. 955(E) Draft Notification for amendment in the Drugs Rules, 1945 for requirement of an authorised person responsible for batch release of product, PDF, opens in a new tab
Comments close about November 28, 2026 to December 3, 2026
30 days from the Gazette of October 29, 2026, put online November 3, 2026
G.S.R. 955(E) ·
- 28.10.2026 G.S.R. 954(E) Draft Amendment of Rule 43A of the Drugs Rules, 1945 to include various ICDs/Port/SEZs for the import of Drugs/ Medical Devices/ Cosmetics in India, PDF, opens in a new tab
Comments close about November 28, 2026 to December 2, 2026
30 days from the Gazette of October 29, 2026, put online November 2, 2026
G.S.R. 954(E) ·
- Draft notification regarding inclusion of all antimicrobial drugs under the definition of new Drugs in the NDCT Rules, 2019, PDF, opens in a new tab
Comments close about December 12 to 18, 2026
30 days from the Gazette of November 12, 2026, put online November 18, 2026
G.S.R. 983(E) ·
- Draft Notification regarding amendment in Schedule M of the Drugs Rules, 1945, for relaxation of requirements relating to medicinal gases, empty gelatin capsules and disinfectant fluids., PDF, opens in a new tab
Comments close about December 12 to 18, 2026
30 days from the Gazette of November 12, 2026, put online November 18, 2026
G.S.R. 985(E) ·
- Draft Notification for Guidelines on Goods Storage and Distribution Practices (GSDP) for Pharmaceutical Products in Drugs Rules, 1945., PDF, opens in a new tab
Comments close about December 12 to 18, 2026
30 days from the Gazette of November 12, 2026, put online November 18, 2026
G.S.R. 984(E) ·
- Draft Notification for amendment in Rule 59 of the Drugs Rules, 1945, regarding licensing requirements for wholesale distribution of bulk drugs, PDF, opens in a new tab
Comments close about December 12 to 18, 2026
30 days from the Gazette of November 12, 2026, put online November 18, 2026
G.S.R. 987(E) ·
Closed, no final rule yet
- Draft proposal for Change in conditions of Retail and Wholesale license w.r.t. advertisement., PDF, opens in a new tab
Comments closed about November 4 to 7, 2026
30 days from the Gazette of October 5, 2026, put online October 8, 2026
G.S.R. 861(E) ·
- Draft notification for amendment in the Drugs Rules 1945 regarding mandatory installation of CCTV surveillance system at sales premises, PDF, opens in a new tab
Comments closed about October 9 to 16, 2026
30 days from the Gazette of September 9, 2026, put online September 16, 2026
G.S.R. 791(E) ·
- Draft notification to amend Schedule K by incorporating Levonorgestrel Tablets 0.75 MG, 1.5mg (emergency Contraceptives) under s.no. 06 of entry no. 15 of Schedule K of the Drugs Rules, 1945, PDF, opens in a new tab
Comments closed about October 9 to 16, 2026
30 days from the Gazette of September 9, 2026, put online September 16, 2026
G.S.R. 792(E) ·
- Draft Notification for extension of prior intimation system for certain BA and BE studies for approval of New Drugs in India, PDF, opens in a new tab
Comments closed about October 9 to 16, 2026
30 days from the Gazette of September 9, 2026, put online September 16, 2026
G.S.R. 790(E) ·
- Draft notification for inclusion of additional four drugs in Schedule H1, PDF, opens in a new tab
Comments closed about September 18 to 20, 2026
30 days from the Gazette of August 19, 2026, put online August 21, 2026
G.S.R. 745(E) ·
- Draft notification regarding amendments under Medical Devices Rules 2017, PDF, opens in a new tab
Comments closed about July 24 to 27, 2026
30 days from the Gazette of June 24, 2026, put online June 27, 2026
G.S.R. 515(E) ·
- Draft notification regarding simplification of the process for obtaining test licences for import of drugs under Form 11 of the Drugs Rules, 1945, PDF, opens in a new tab
Comments closed about July 23 to 26, 2026
30 days from the Gazette of June 23, 2026, put online June 26, 2026
G.S.R. 509(E) ·
- Draft notification regarding submission of Periodic Safety Update Reports annually for subsequent years till the drug product is marketed in the NDCT Rules, 2019, PDF, opens in a new tab
Comments closed about July 22 to 25, 2026
30 days from the Gazette of June 22, 2026, put online June 25, 2026
G.S.R. 504(E) ·
- Draft Notification reg PAC for amendment in Drugs Rules, 1945, PDF, opens in a new tab
Comments closed April 10, 2026
30 days from the Gazette of March 11, 2026
G.S.R. 173(E) ·
- Draft Notification regarding Blood product testing under Drugs Rules,1945, PDF, opens in a new tab
Comments closed April 9, 2026
30 days from the Gazette of March 10, 2026
G.S.R. 164(E) ·
- Draft Notification regarding amendment in NDCT Rules, 2019 for Omit the requirements of granting of Provisional Certificate for registration of ethics committee., PDF, opens in a new tab
Comments closed about March 5 to 7, 2026
30 days from the Gazette of February 3, 2026, put online February 5, 2026
G.S.R. 98(E) ·
- Draft Notification regarding submission of post approval changes in NDCT, Rules 2019, PDF, opens in a new tab
Comments closed about March 5 to 6, 2026
30 days from the Gazette of February 3, 2026, put online February 4, 2026
G.S.R. 97(E) ·
- Draft Notification for exemption of Animal Toxicity Studies w.r.t. certain conditions, PDF, opens in a new tab
Comments closed about February 19 to 26, 2026
30 days from the Gazette of January 20, 2026, put online January 27, 2026
G.S.R. 45(E) ·
- Draft Notification regarding Blue line on Label of Antimicrobial, PDF, opens in a new tab
Comments closed about February 21 to 22, 2026
30 days from the Gazette of January 22, 2026, put online January 23, 2026
G.S.R. 51(E) ·
- Draft Notification for amendment in Medical Device Rules, 2017, PDF, opens in a new tab
Comments closed about January 3 to 12, 2026
30 days from the Gazette of December 4, 2025, put online December 13, 2025
G.S.R. 883(E) ·
Became final
- Notification regarding rationalization of shelf life under Rule 31 of Drugs Rules, 1945, PDF, opens in a new tab
From the draft G.S.R. 505(E) (PDF, opens in a new tab) of June 22, 2026, made final 128 days later
Public comments were received and considered. The draft was made public on June 25, 2026
G.S.R. 951(E) ·
- Amendment in MD Rules, 2017 for inclusion of EU countries in Rule 63 & QMS requirements for Class A NSNM, PDF, opens in a new tab
From the draft G.S.R. 269(E) (PDF, opens in a new tab) of April 10, 2026, made final 126 days later
Public comments were received and considered. The draft was made public on April 10, 2026
G.S.R. 744(E) ·
- Amendment in MD Rules, 2017 for introduction of Ninth Schedule and labelling requirements for sterilization activities, PDF, opens in a new tab
From the draft G.S.R. 270(E) (PDF, opens in a new tab) of April 10, 2026, made final 126 days later
Public comments were received and considered. The draft was made public on April 10, 2026
G.S.R. 743(E) ·
- Notification for amendment under Rule 89 of Drugs Rules 1945, for obtaining licence under Form 29 for different categories falling under Form 25A, 25F, 28A, 28B, 28D, 28DA, 28E, 28F, PDF, opens in a new tab
From the draft G.S.R. 299(E) (PDF, opens in a new tab) of April 21, 2026, made final 107 days later
Public comments were received and considered. The draft was made public on April 22, 2026
G.S.R. 713(E) ·
- Notification regarding Debarment of applicant for submitting misleading, or fake, or Fabricated Documents, information, PDF, opens in a new tab
From the draft G.S.R. 756(E) (PDF, opens in a new tab) of October 16, 2025, made final 287 days later
Public comments were received and considered. The draft was made public on October 28, 2025
G.S.R. 706(E) ·
- Notification regarding restriction of sale of drug products containing alcohol content under Drugs Rules 1945, PDF, opens in a new tab
From the draft G.S.R. 760(E) (PDF, opens in a new tab) of October 16, 2025, made final 265 days later
No public comments were received. The draft was made public on October 18, 2025
G.S.R. 607(E) ·
- Notification for consideration of Navi Mumbai International Airport (NMIA) as authorized Airport for Drug Import, under the provision of Rule 43A of Drugs Rules 1945, PDF, opens in a new tab
From the draft G.S.R. 66(E) (PDF, opens in a new tab) of January 28, 2026, made final 155 days later
No public comments were received. The draft was made public on January 28, 2026
G.S.R. 561(E) ·
- Notification regarding Inclusion of additional items under CLAA in Drugs Rules 1945, PDF, opens in a new tab
From the draft G.S.R. 758(E) (PDF, opens in a new tab) of October 16, 2025, made final 256 days later
No public comments were received. The draft was made public on October 18, 2025
G.S.R. 530(E) ·
- Notification regarding amendment under Drugs Rules to include more categories under Schedule H2, PDF, opens in a new tab
From the draft G.S.R. 757(E) (PDF, opens in a new tab) of October 16, 2025, made final 249 days later
Public comments were received and considered. The draft was made public on October 18, 2025
G.S.R. 506(E) ·
- Notification of Chaudhary Charan Singh National Institute of Animal Health, Baghpat, UP, as a CDL for testing viral and bacterial veterinary vaccines under the D and C Act, PDF, opens in a new tab
From the draft G.S.R. 65(E) (PDF, opens in a new tab) of January 28, 2026, made final 141 days later
No public comments were received. The draft was made public on January 31, 2026
G.S.R. 496(E) ·
- Notification for Removal of Syrup exemption under schedule K in the Drugs Rules,1945, PDF, opens in a new tab
From the draft G.S.R. 927(E) (PDF, opens in a new tab) of December 29, 2025, made final 162 days later
Public comments were received and considered. The draft was made public on December 30, 2025
G.S.R. 477(E) ·
- Notification for amendment in Schedule V w.r.t. unit of measurement of Folic Acid under the Drugs Rules, 1945, PDF, opens in a new tab
From the draft G.S.R. 53(E) (PDF, opens in a new tab) of January 21, 2026, made final 131 days later
Public comments were received and considered. The draft was made public on January 27, 2026
G.S.R. 444(E) ·
- Notification for Revision of testing fees under Schedule B and B1 of Drugs and Cosmetics Act, PDF, opens in a new tab
From the draft G.S.R. 52(E) (PDF, opens in a new tab) of January 22, 2026, made final 120 days later
No public comments were received. The draft was made public on January 27, 2026
G.S.R. 407(E) ·
- Notification for amendment in Schedule H1 for inclusion of Pregabalin and its drug formulations, PDF, opens in a new tab
From the draft G.S.R. 54(E) (PDF, opens in a new tab) of January 21, 2026, made final 112 days later
Public comments were received and considered. The draft was made public on January 27, 2026
G.S.R. 377(E) ·
- Inclusion of Qualifications of Inspector Medical Devices and Government Analyst, PDF, opens in a new tab
From the draft G.S.R. 748(E) (PDF, opens in a new tab) of October 10, 2025, made final 143 days later
Public comments were received and considered. The draft was made public on October 10, 2025
G.S.R. 165(E) ·
- Notification for amendment in certain Drugs Rules (Related to Rule 121 – Test for Pyrogen, Footnote of Schedule H, condition of license under Form 20B, 20BB, 21B, 21BB, inclusion of name of competent person in Form 20G), PDF, opens in a new tab
From the draft G.S.R. 345(E) (PDF, opens in a new tab) of May 28, 2025, made final 264 days later
Public comments were received and considered. The draft was made public on May 28, 2025
G.S.R. 135(E) ·
- Notification for amendment in NDCT Rules, 2019 for online intimation mechanism for BA BE studies of unapproved drugs for export purpose, PDF, opens in a new tab
From the draft G.S.R. 587(E) (PDF, opens in a new tab) of August 27, 2025, made final 147 days later
Public comments were received and considered. The draft was made public on August 28, 2025
G.S.R. 50(E) ·
- Notification about changes to requirements of Test license under NDCT Rules 2019, PDF, opens in a new tab
From the draft G.S.R. 588(E) (PDF, opens in a new tab) of August 27, 2025, made final 146 days later
Public comments were received and considered. The draft was made public on August 28, 2025
G.S.R. 46(E) ·
- Prohibit the import, manufacture, sale and distribution of certain antimicrobial products for animal use, PDF, opens in a new tab
From the draft S.O. 2298(E) (PDF, opens in a new tab) of May 22, 2025, made final 124 days later
No public comments were received. The draft was made public on May 22, 2025
S.O. 4338(E) ·
- Inclusion of details of excipient on every strip of medicines under Rule 96, in sub-rule (7) of Drugs Rules, 1945, PDF, opens in a new tab
From the draft G.S.R. 391(E) (PDF, opens in a new tab) of July 12, 2024, made final 402 days later
Public comments were received and considered. The draft was made public on July 12, 2024
G.S.R. 554(E) ·
- Certain amendments in Cosmetics Rule 2020, PDF, opens in a new tab
From the draft G.S.R. 371(E) (PDF, opens in a new tab) of May 15, 2023, made final 806 days later
Public comments were received and considered. The draft was made public on May 17, 2023
G.S.R. 513(E) ·
- Notification reg rules for Compounding of offences under Jan Vishwas Act, PDF, opens in a new tab
From the draft G.S.R. 374(E) (PDF, opens in a new tab) of July 10, 2024, made final 288 days later
Public comments were received and considered. The draft was made public on July 10, 2024
G.S.R. 259(E) ·
- Notification reg Extension of timeline for implementation of Schedule M, PDF, opens in a new tab
From the draft G.S.R. 10(E) (PDF, opens in a new tab) of January 4, 2025, made final 38 days later
Public comments were received and considered. The draft was made public on January 4, 2025
G.S.R. 127(E) ·
- Notification for registration of Clinical Research Organisation CRO, PDF, opens in a new tab
From the draft G.S.R. 364(E) (PDF, opens in a new tab) of May 11, 2023, made final 497 days later
Public comments were received and considered. The draft was made public on May 11, 2023
G.S.R. 581(E) ·
- Inclusion of Cochin and Thiruvananthapuram Ports in Rule 43A of Drugs Rules, 1945, PDF, opens in a new tab
From the draft G.S.R. 139(E) (PDF, opens in a new tab) of February 27, 2024, made final 91 days later
No public comments were received. The draft was made public on February 27, 2024
G.S.R. 293(E) ·
- Omission of Glyceryl Trinitrate and Isosorbide Dinitrate from Schedule P1 and modification in Rule 105, PDF, opens in a new tab
From the draft G.S.R. 687(E) (PDF, opens in a new tab) of September 25, 2023, made final 175 days later
Public comments were received and considered. The draft was made public on September 26, 2023
G.S.R. 216(E) ·
- Inclusion of Oseltamivir and Zanamivir in Schedule H1, PDF, opens in a new tab
From the draft G.S.R. 686(E) (PDF, opens in a new tab) of September 25, 2023, made final 133 days later
Public comments were received and considered. The draft was made public on September 25, 2023
G.S.R. 95(E) ·
November 2026
- Cancellation of Import permission - 374/10, Registration certificate- SVH-I, SVH-I and Import licence- SVH-1-126 granted for purified TT & Bordetella of M/s Sanofi Healthcare India Private, PDF, opens in a new tab
- Reminder for onboarding of State/UT officials and Drug Testing Laboratories on SUGAM Labs Portal, PDF, opens in a new tab
- Draft notification regarding inclusion of all antimicrobial drugs under the definition of new Drugs in the NDCT Rules, 2019, PDF, opens in a new tab
G.S.R. 983(E) ·
- Draft Notification regarding amendment in Schedule M of the Drugs Rules, 1945, for relaxation of requirements relating to medicinal gases, empty gelatin capsules and disinfectant fluids., PDF, opens in a new tab
G.S.R. 985(E) ·
- Draft Notification for Guidelines on Goods Storage and Distribution Practices (GSDP) for Pharmaceutical Products in Drugs Rules, 1945., PDF, opens in a new tab
G.S.R. 984(E) ·
- Draft Notification for amendment in Rule 59 of the Drugs Rules, 1945, regarding licensing requirements for wholesale distribution of bulk drugs, PDF, opens in a new tab
G.S.R. 987(E) ·
October 2026
- 28.10.2026 G.S.R. 956(E) Draft Notification for amendment in the Drugs Rules, 1945 for suspension of product permission for NSQ drug till CAPA is implemented, PDF, opens in a new tab
G.S.R. 956(E) ·
- 28.10.2026 G.S.R. 953(E) Draft Notification for amendment in Drugs Rules, 1945 for Revision of Microbial Contamination Limits for Grade A Areas under Schedule M to align with WHO Standards, PDF, opens in a new tab
G.S.R. 953(E) ·
- 28.10.2026 G.S.R. 955(E) Draft Notification for amendment in the Drugs Rules, 1945 for requirement of an authorised person responsible for batch release of product, PDF, opens in a new tab
G.S.R. 955(E) ·
- 28.10.2026 G.S.R. 954(E) Draft Amendment of Rule 43A of the Drugs Rules, 1945 to include various ICDs/Port/SEZs for the import of Drugs/ Medical Devices/ Cosmetics in India, PDF, opens in a new tab
G.S.R. 954(E) ·
- Notification regarding rationalization of shelf life under Rule 31 of Drugs Rules, 1945, PDF, opens in a new tab
From the draft G.S.R. 505(E) (PDF, opens in a new tab) of June 22, 2026
G.S.R. 951(E) ·
- Appointment of Central Compounding Authority Order, PDF, opens in a new tab
- Misleading or false claims of the product FatX solution registered under COS-2 vide RC no. RC/COS-003300 by the firm M/s Tekno Midas Aesthetics, PDF, opens in a new tab
- Digital Monitoring System on the ONDLS portal for monitoring the supply chain of high-risk solvents., PDF, opens in a new tab
- Strict compliance with the Drugs Rules, 1945, for testing of raw materials and finished formulations, PDF, opens in a new tab
- WHO Alert on falsified DEFITELIO (Defibrotide) 80 mg/ml concentrate for solution for infusion, B. No. 24GC01A, Exp date 04/2027, Mfg by: Patheon, II Trav. sx Via Morolense, 5, 03013 Ferentino (FR) Italy and Marketing authorisation holder: Gentium S.r.l, Piazza XX Settembre, 2, 22079 Villa Guardia (Como) Italy and identified in India, PDF, opens in a new tab
- Clarification regarding requirement of Export NOC for already approved r-DNA products., PDF, opens in a new tab
- Notification of Government Analysts for veterinary vaccines at CCSNIAH, Baghpat, PDF, opens in a new tab
S.O. 5617(E) ·
- Draft Guidance document for Manufacturers of In-vitro diagnostic Medical device for stakeholders comment, PDF, opens in a new tab
- Surrender of Cosmetic Registration Certificate No. RC/COS-005067 dated 05.07.2024, PDF, opens in a new tab
September 2026
- Draft proposal for Change in conditions of Retail and Wholesale license w.r.t. advertisement., PDF, opens in a new tab
G.S.R. 861(E) ·
- Indiscriminate use of painkillers (NSAIDs), antibiotics and associated risk of Chronic Kidney Disease, PDF, opens in a new tab
- Public Health alert against the use of unauthorised Cosmetics Products, PDF, opens in a new tab
- Draft notification for amendment in the Drugs Rules 1945 regarding mandatory installation of CCTV surveillance system at sales premises, PDF, opens in a new tab
G.S.R. 791(E) ·
- Drug Regulatory and Law Enforcement Agencies Intensify Coordinated Action Against Illegal Manufacture and Distribution of Misbranded Drugs, PDF, opens in a new tab
- Draft notification to amend Schedule K by incorporating Levonorgestrel Tablets 0.75 MG, 1.5mg (emergency Contraceptives) under s.no. 06 of entry no. 15 of Schedule K of the Drugs Rules, 1945, PDF, opens in a new tab
G.S.R. 792(E) ·
- Draft Notification for extension of prior intimation system for certain BA and BE studies for approval of New Drugs in India, PDF, opens in a new tab
G.S.R. 790(E) ·
- Prohibition of manufacture, import, sale and distribution of Carboxypenicillins and Phosphonic acid derivatives for animal use., PDF, opens in a new tab
S.O. 4996(E) ·
- Cancellation order dated 24.08.2026 (Skintle Enterprises Pvt Ltd), PDF, opens in a new tab
August 2026
- Draft notification for inclusion of additional four drugs in Schedule H1, PDF, opens in a new tab
G.S.R. 745(E) ·
- Prohibition of all formulations of FDC containing Chlorpheniramine Maleate and Phenylephrine HCl in children below four years of age, PDF, opens in a new tab
S.O. 4595(E) ·
- Amendment in MD Rules, 2017 for inclusion of EU countries in Rule 63 & QMS requirements for Class A NSNM, PDF, opens in a new tab
From the draft G.S.R. 269(E) (PDF, opens in a new tab) of April 10, 2026
G.S.R. 744(E) ·
- Amendment in MD Rules, 2017 for introduction of Ninth Schedule and labelling requirements for sterilization activities, PDF, opens in a new tab
From the draft G.S.R. 270(E) (PDF, opens in a new tab) of April 10, 2026
G.S.R. 743(E) ·
- Manufacturing and marketing of un-approved drug products containing Enclomiphene and its combinations, PDF, opens in a new tab
- Clarification on the submission of applications for grant of Permission to Import and Market New Drugs not approved anywhere in the world, wherein phase III Global Clinical Trials (GCT) are ongoing or completed with participation of Indian subjects under the New Drugs and Clinical Trials Rules, 2019, PDF, opens in a new tab
- Notification for amendment under Rule 89 of Drugs Rules 1945, for obtaining licence under Form 29 for different categories falling under Form 25A, 25F, 28A, 28B, 28D, 28DA, 28E, 28F, PDF, opens in a new tab
From the draft G.S.R. 299(E) (PDF, opens in a new tab) of April 21, 2026
G.S.R. 713(E) ·
- Stakeholder Consultation on Operational Guidelines for Single Ethics Committee Review of Multi-Centre Research in India, PDF, opens in a new tab
July 2026
- Notification regarding Debarment of applicant for submitting misleading, or fake, or Fabricated Documents, information, PDF, opens in a new tab
From the draft G.S.R. 756(E) (PDF, opens in a new tab) of October 16, 2025
G.S.R. 706(E) ·
- Regulatory Alert regarding Cancellation of Registration Certificates of Ethics Committees under the New Drugs and Clinical Trials Rules, 2019, PDF, opens in a new tab
- Vigilance on imported cosmetics products sold in the domestic market without valid lmport Registration certificate, PDF, opens in a new tab
- Surrender of cosmetic Registration Certificate No. RC/COS-003938 dated 23.08.2023, PDF, opens in a new tab
- Clarification regarding submission of applications under Rule 4 of the Drugs and Cosmetics (Compounding of Offences) Rules, 2025., PDF, opens in a new tab
- Surrender of Cosmetic Registration Certificate No RC/COS-002707 dated 06-Oct. 2021 and RC/COS-002885 dated 3-Jan-2022, PDF, opens in a new tab
- Surrender of Cosmetic Registration Certificate No RC/COS-002497 daled 08-Jul- 2021, PDF, opens in a new tab
- Guidance document on Medical Device Software under MDR-2017, PDF, opens in a new tab
- Inviting comments on standard IVD evaluation draft protocols Scrub Typhus drafted by ICMR and CDSCO, PDF, opens in a new tab
- Notification regarding restriction of sale of drug products containing alcohol content under Drugs Rules 1945, PDF, opens in a new tab
From the draft G.S.R. 760(E) (PDF, opens in a new tab) of October 16, 2025
G.S.R. 607(E) ·
- Inviting comments on consideration of the proposal regarding Issue of use of brand name extensions by the pharmaceutical firms, PDF, opens in a new tab
- Notification for consideration of Navi Mumbai International Airport (NMIA) as authorized Airport for Drug Import, under the provision of Rule 43A of Drugs Rules 1945, PDF, opens in a new tab
From the draft G.S.R. 66(E) (PDF, opens in a new tab) of January 28, 2026
G.S.R. 561(E) ·
June 2026
- Notification regarding Inclusion of additional items under CLAA in Drugs Rules 1945, PDF, opens in a new tab
From the draft G.S.R. 758(E) (PDF, opens in a new tab) of October 16, 2025
G.S.R. 530(E) ·
- CDSCO updated list of laboratories to conduct Performance evaluation of IVDs dated 29/06/2026, PDF, opens in a new tab
- Submission of Post Approval Changes Applications of Registration Certificate and Import Licence of Human Vaccines and Anti-sera through SUGAM Portal, PDF, opens in a new tab
- Regulation of Formulation intermediates such as Directly Compressible granules, Taste masked granules, Modified release granules / Pellets, PDF, opens in a new tab
- Sale of In-Vitro Fertilization media, reagents and related consumables used in Assisted Reproductive Technology procedures, PDF, opens in a new tab
- Draft notification regarding amendments under Medical Devices Rules 2017, PDF, opens in a new tab
G.S.R. 515(E) ·
- Draft notification regarding simplification of the process for obtaining test licences for import of drugs under Form 11 of the Drugs Rules, 1945, PDF, opens in a new tab
G.S.R. 509(E) ·
- Draft notification regarding rationalization of shelf life under Rule 31 of Drugs Rules, 1945, PDF, opens in a new tab
Made final by G.S.R. 951(E) (PDF, opens in a new tab) of October 28, 2026
G.S.R. 505(E) ·
- Draft notification regarding submission of Periodic Safety Update Reports annually for subsequent years till the drug product is marketed in the NDCT Rules, 2019, PDF, opens in a new tab
G.S.R. 504(E) ·
- Notification regarding amendment under Drugs Rules to include more categories under Schedule H2, PDF, opens in a new tab
From the draft G.S.R. 757(E) (PDF, opens in a new tab) of October 16, 2025
G.S.R. 506(E) ·
- Implementation of provisions under Jan Vishwas (Amendment of Provisions) Act, 2026, PDF, opens in a new tab
S.O. 3286(E) ·
- Notification of Chaudhary Charan Singh National Institute of Animal Health, Baghpat, UP, as a CDL for testing viral and bacterial veterinary vaccines under the D and C Act, PDF, opens in a new tab
From the draft G.S.R. 65(E) (PDF, opens in a new tab) of January 28, 2026
G.S.R. 496(E) ·
- Constitution of Consultancy Committee of Key Stakeholders for Advice on Suo-Motu Disclosure under Section 4 of the RTI Act, 2005 in CDSCO, PDF, opens in a new tab
- List of Debarment of Principal Investigators by CLA, PDF, opens in a new tab
- List of Suspended Ethics Committee by CLA, PDF, opens in a new tab
- Prohibition of 16 FDCs, PDF, opens in a new tab
S.O. 3068(E), S.O. 3083(E) ·
- Submission of Compliance for lmported/manufactured Hair Color Cosmetics Products as per Cosmetics Rules, 2020 and applicable BIS Standards, PDF, opens in a new tab
- Notification for Removal of Syrup exemption under schedule K in the Drugs Rules,1945, PDF, opens in a new tab
From the draft G.S.R. 927(E) (PDF, opens in a new tab) of December 29, 2025
G.S.R. 477(E) ·
- Prohibits to Import, manufacture, sale, distribution and use in any food producing animal rearing system of drug formulations containing "Chloramphenicol or Nitrofurans drugs with immediate effect, PDF, opens in a new tab
- Transfer List 2025, PDF, opens in a new tab
- Implementation of Pharmacovigilance (PV) System as per the requirement of Schedule M of Drugs & Cosmetics Act 1940 and the Rules made there under, PDF, opens in a new tab
- Notification for amendment in Schedule V w.r.t. unit of measurement of Folic Acid under the Drugs Rules, 1945, PDF, opens in a new tab
From the draft G.S.R. 53(E) (PDF, opens in a new tab) of January 21, 2026
G.S.R. 444(E) ·
May 2026
- Revised Regulatory Guidelines For Sampling Of Drugs, Cosmetics & Medical Devices By Drugs Inspectors Of Central & State Drug Authorities, PDF, opens in a new tab
- Notification for Revision of testing fees under Schedule B and B1 of Drugs and Cosmetics Act, PDF, opens in a new tab
From the draft G.S.R. 52(E) (PDF, opens in a new tab) of January 22, 2026
G.S.R. 407(E) ·
- BE-NOC Prior Intimation (System of Notification for certain category of new drugs for conduct of "BA-BE Studies" for export purpose under Chapter V, NDCT Rule, 2019) and procedure for obtaining CT-16 application on NSWS Portal, PDF, opens in a new tab
- Use of Cosmetics, PDF, opens in a new tab
- Strengthening Enforcement against Unauthorized Promotion and Distribution of GLP-1 Based Drugs, PDF, opens in a new tab
- Rejection and Debarment of application for submission of fabricated documents by firm M/s. DMF Cosmo Private Limited, PDF, opens in a new tab
- Notification for amendment in Schedule H1 for inclusion of Pregabalin and its drug formulations, PDF, opens in a new tab
From the draft G.S.R. 54(E) (PDF, opens in a new tab) of January 21, 2026
G.S.R. 377(E) ·
- Restriction on shifting/reallocation of IT equipment without prior intimation and approval of Administration and IT cell of CDSCO(HQ), PDF, opens in a new tab
- Appointment of CPIO for the purpose of RTI(Technical) Matters, PDF, opens in a new tab
- Cancellation of a product "Elementre - MD Peel-Tri AHA" under Registration Certificate No. RC/COS-005139 dated 15-Jul2O24 valid upto 14-Jul2O29 for import under Cosmetics Rules, 2020- Regarding, PDF, opens in a new tab
- Disposal/Rejection of Long Pending Applications on SUGAM Portal Awaiting Query Response, PDF, opens in a new tab
April 2026
- COVID-19 vaccines approved in the country as on 22.04.2026, PDF, opens in a new tab
- Submission of Periodic Safety Update Reports (PSURs) for New Drugs via SUGAM Portal on deferred basis in case of delayed Marketing after Approval, PDF, opens in a new tab
- Draft Notification for amendment under Rule 89 of Drugs Rules 1945, for obtaining licence under Form 29 for different categories falling under Form 25A, 25F, 28A, 28B, 28D, 28DA, 28E, 28F, PDF, opens in a new tab
Made final by G.S.R. 713(E) (PDF, opens in a new tab) of August 6, 2026
G.S.R. 299(E) ·
- Circular on Implementation of Prior intimation System for Form CT-05 application (for export purpose only) w.e.f 21.04.2026 in pursuance of G.S.R 50(E) dated 21.01.2026, PDF, opens in a new tab
G.S.R. 50(E) ·
- Draft Notification to amend certain provisions under Medical Devices Rules, 2017 EU, PDF, opens in a new tab
Made final by G.S.R. 743(E) (PDF, opens in a new tab) of August 14, 2026
G.S.R. 270(E) ·
- Draft Notification to amend certain provisions w.r.t. Medical Device Testing Fee under MDR, 2017, PDF, opens in a new tab
Made final by G.S.R. 744(E) (PDF, opens in a new tab) of August 14, 2026
G.S.R. 269(E) ·
March 2026
- Import, manufacturing, sale etc. of medical devices intended for InVitro Fertilization viz., IUI (Intrauterine Insemination) kits, centrifuge for sperm washing etc. used for Assisted Reproductive Technology related procedures, PDF, opens in a new tab
- Streamlining the procedure for disposal of applications for "Written Confirmation" (WC) for Active Substances Exported to the EU for Human Use in accordance with Article 46(2)(b) of Directive 2001/83/EC received in CDSCO SUGAM Portal, PDF, opens in a new tab
- Regulation & Mandatory Registration of Licensed Blood Centres on the e-RaktKosh Portal, PDF, opens in a new tab
- Manufacturing and marketing of unapproved drug product Sodium Hyaluronate Eye Drops 0.3% w/v, PDF, opens in a new tab
- Guidance document on dossier based licensing of Drugs for uniform product licensing in the country, PDF, opens in a new tab
- Addendum to Doc No. CDSCO. IVD. FAQ. 04. 2022 dated 13.03.2026, PDF, opens in a new tab
- Transfer of certain functions and delegation of powers to the zonal offices of CDSCO under Rule 22 of the Drugs and Cosmetics Rules, 1945, PDF, opens in a new tab
- Cancellation of products under RC/COS-005358, for import of Cosmetics under Cosmetics Rules, 2020 (M/s. Beauty Garage India Pvt ltd), PDF, opens in a new tab
- Testing Laboratories approved by Statas & UT in Form 37 of Drugs Rule 1945 and Cos 23 of Cosmetics Rule 2020, PDF, opens in a new tab
- Online Applications for grant of license in Form 28-D/28-DA for r-DNA products, PDF, opens in a new tab
- Draft Notification reg PAC for amendment in Drugs Rules, 1945, PDF, opens in a new tab
G.S.R. 173(E) ·
- Draft Notification regarding Blood product testing under Drugs Rules,1945, PDF, opens in a new tab
G.S.R. 164(E) ·
- Online Applications for Post Approval Changes (PAC) w.r.t Marketing Authorization (MA) for r-DNA products, PDF, opens in a new tab
- Implementation of Prior intimation System for Forms CT-10, CT-12 and CT-13 in pursuance of G.S.R. 46(E) dated 20.01.2026, PDF, opens in a new tab
G.S.R. 46(E) ·
- Alert on theft of Lantus® SoloStar® (Insulin Glargine Injection IP, r‑DNA origin, 100 IU/mL Batch No. 5F0347B of M/s Sanofi India Limited during transit, PDF, opens in a new tab
- Inclusion of Qualifications of Inspector Medical Devices and Government Analyst, PDF, opens in a new tab
From the draft G.S.R. 748(E) (PDF, opens in a new tab) of October 10, 2025
G.S.R. 165(E) ·
February 2026
- Testing of drugs for grant of permissions for import/manufacture of New Drug for sale or for distribution and Issuance of RC for import of Drugs etc, PDF, opens in a new tab
- Cancellation of Registration Certificates and lmport Registration Numbers for lmport of Cosmetics under the Cosmetics Rules, 2020- Regarding, PDF, opens in a new tab
- Notification of Medical Device Testing Officers (MDTO) for Laboratories, PDF, opens in a new tab
S.O. 912(E) ·
- Carbimazole related agranulocytosis - Recommendations for the change in Prescribing Information Leaflets (PILs), PDF, opens in a new tab
- Doxycycline related CNS Side Effects (Restlessness, Anxiety, Irritability, Nervousness, and Dizziness) - Recommendations for the change in Prescribing Information Leaflets (PILs), PDF, opens in a new tab
- Notification for amendment in certain Drugs Rules (Related to Rule 121 – Test for Pyrogen, Footnote of Schedule H, condition of license under Form 20B, 20BB, 21B, 21BB, inclusion of name of competent person in Form 20G), PDF, opens in a new tab
From the draft G.S.R. 345(E) (PDF, opens in a new tab) of May 28, 2025
G.S.R. 135(E) ·
- Provision for Risk Classification of In-Vitro Diagnostic Medical Devices on the CDSCO Online System for Medical Devices, PDF, opens in a new tab
- Draft Notification regarding amendment in NDCT Rules, 2019 for Omit the requirements of granting of Provisional Certificate for registration of ethics committee., PDF, opens in a new tab
G.S.R. 98(E) ·
- Draft Notification regarding submission of post approval changes in NDCT, Rules 2019, PDF, opens in a new tab
G.S.R. 97(E) ·
- Draft Guidance document for Import of In-vitro diagnostic Medical device for stakeholders comment (dated 30.01.2026), PDF, opens in a new tab
January 2026
- Draft notification of Chaudhary Charan Singh National Institute of Animal Health, Baghpat, UP, as a CDL for testing viral and bacterial veterinary vaccines under the D and C Ac, PDF, opens in a new tab
Made final by G.S.R. 496(E) (PDF, opens in a new tab) of June 18, 2026
G.S.R. 65(E) ·
- Draft Notification for consideration of Navi Mumbai International Airport (NMIA) as authorized Airport for Drug Import, under the provision of Rule 43A of Drugs Rules 1945, PDF, opens in a new tab
Made final by G.S.R. 561(E) (PDF, opens in a new tab) of July 2, 2026
G.S.R. 66(E) ·
- Cancellation of products underRC/COS-001655, for import of Cosmetics under Cosmetics Rules, 2020, PDF, opens in a new tab
- Draft Notification for Revision of testing fees under Schedule B and B1, PDF, opens in a new tab
Made final by G.S.R. 407(E) (PDF, opens in a new tab) of May 22, 2026
G.S.R. 52(E) ·
- Draft Notification for amendment in Schedule V w.r.t. unit of measurement of Folic Acid under the Drugs Rules, 1945, PDF, opens in a new tab
Made final by G.S.R. 444(E) (PDF, opens in a new tab) of June 1, 2026
G.S.R. 53(E) ·
- Draft Notification for amendment in Schedule H1 for inclusion of Pregabalin and its drug formulations, PDF, opens in a new tab
Made final by G.S.R. 377(E) (PDF, opens in a new tab) of May 13, 2026
G.S.R. 54(E) ·
- Notification for amendment in NDCT Rules, 2019 for online intimation mechanism for BA BE studies of unapproved drugs for export purpose, PDF, opens in a new tab
From the draft G.S.R. 587(E) (PDF, opens in a new tab) of August 27, 2025
G.S.R. 50(E) ·
- Draft Notification regarding Blue line on Label of Antimicrobial, PDF, opens in a new tab
G.S.R. 51(E) ·
- Draft Notification for exemption of Animal Toxicity Studies w.r.t. certain conditions, PDF, opens in a new tab
G.S.R. 45(E) ·
- Notification about changes to requirements of Test license under NDCT Rules 2019, PDF, opens in a new tab
From the draft G.S.R. 588(E) (PDF, opens in a new tab) of August 27, 2025
G.S.R. 46(E) ·
- CDSCO updated list of Laboratories for conducting Performance Evaluation of In-Vitro Diagnostic Medical Device, PDF, opens in a new tab
- Disposal/Rejection of Long-Pending Applications on Sugam Portal Awaiting Query Response, PDF, opens in a new tab
- Risk classification list of medical devices pertaining to Oncology, PDF, opens in a new tab
- SoP - Compounding of Offences Rules, 2025, PDF, opens in a new tab
- Guidelines on Compounding of Offences under the Drugs and Cosmetics Act, 1940 as per Drugs and Cosmetics (Compounding of Offences) Rules, 2025, PDF, opens in a new tab
- Compounding of Offences under the Drugs and Cosmetics Act, 1940 in accordance with the Drugs and Cosmetics (Compounding of Offences) Rules, 2025, PDF, opens in a new tab
- FAQs on Drugs and Cosmetics (Compounding of Offences) Rules, 2025, PDF, opens in a new tab